IBS: Lubiprostone: trials and tribulations

@article{Crowell2009IBSLT,
  title={IBS: Lubiprostone: trials and tribulations},
  author={Michael D Crowell},
  journal={Nature Reviews Gastroenterology &Hepatology},
  year={2009},
  volume={6},
  pages={259-260}
}
the selective, chloride channel 2 activator, lubiprostone, facilitates intestinal-fluid secretion and stimulates gastrointestinal motility. these effects increase stool frequency and improve abdominal discomfort for patients with constipation-predominant IBs, which makes lubiprostone the newest addition to the treatment armamentarium for these patients. Findings from a new, pivotal, phase III study by Drossman and colleagues support the use of lubiprostone in such patients. 
Highly Cited
This paper has 965 citations. REVIEW CITATIONS

1 Figure or Table

Topics

Statistics

05001000201020112012201320142015201620172018
Citations per Year

965 Citations

Semantic Scholar estimates that this publication has 965 citations based on the available data.

See our FAQ for additional information.